Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device

Circulation Journal

Volumn 76, Issue 8, 2012, Pages 1895-1903

  Imamura, Teruhiko ^a   Kinugawa, Koichiro ^a   Shiga, Taro ^a   Endo, Miyoko ^a   Kato, Naoko ^a   Inaba, Toshiro ^a   Maki, Hisataka ^a   Hatano, Masaru ^a   Yao, Atsushi ^a   Nishimura, Takashi ^a   Hirata, Yasunobu ^a   Kyo, Shunei ^a   Ono, Minoru ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Continuous flow; Heart failure; Prognosis; Right ventricular dysfunction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BICARBONATE; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHLORIDE ION; CHOLESTEROL; CREATINE KINASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; LACTATE DEHYDROGENASE; POTASSIUM ION; SODIUM ION; TRIACYLGLYCEROL;

ADULT; APACHE; ARTICLE; CENTRAL VENOUS PRESSURE; COLOMBIA; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLE SIZE; HUMAN; IMPLANTATION; LEFT VENTRICULAR ASSIST DEVICE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; THROMBOCYTE; TODAI VAD SCORING SYSTEM; UREA NITROGEN BLOOD LEVEL; URIC ACID URINE LEVEL;

ADULT; BILIRUBIN; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; SERUM ALBUMIN; SURVIVAL RATE;

EID: 84864391981     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0182     Document Type: Article

References (24)

1. Kinugawa K. How to treat stage D heart failure? When to implant left ventricular assist devices in the era of continuous flow pumps? Circ J 2011; 75: 2038-2045.
2. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS Annual Report: The evolution of destination therapy in the United States. J Heart Lung Transplant 2011; 30: 115-123.
3. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation 2006; 113: 1424-1433.
4. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: Implications for patient selection. Circulation 2007; 116: 497-505.
5. Kirklin JK, Naftel DC, Stevenson LW, Kormos RL, Pagani FD, Miller MA, et al. INTERMACS database for durable devices for circulatory support: First annual report. J Heart Lung Transplant 2008; 27: 1065-1072.
6. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829.
7. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg 2003; 125: 855-862.
8. Holman WL, Kormos RL, Naftel DC, Miller MA, Pagani FD, Blume E, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: A multi-institutional study. J Heart Lung Transplant 2009; 28: 44-50.
9. Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yoshikawa Y, Yamauchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74: 715-722.
10. Saito S, Matsumiya G, Sakaguchi T, Fujita T, Kuratani T, Ichikawa H, et al. Fifteen-year experience with Toyobo paracorporeal left ventricular assist system. J Artif Organs 2009; 12: 27-34.
11. Shiga T, Kinugawa K, Hatano M, Yao A, Nishimura T, Endo M, et al. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J 2010; 75: 121-128.
12. Schaffer JM, Allen JG, Weiss ES, Patel ND, Russell SD, Shah AS, et al. Evaluation of risk indices in continuous-flow left ventricular assist device patients. Ann Thorac Surg 2009; 88: 1889-1896.
13. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-2667.
14. Gracin N, Johnson MR, Spokas D, Allen J, Bartlett L, Piccione W, et al. The use of APACHE II scores to select candidates for left ventricular assist device placement: Acute physiology and chronic health evaluation. J Heart Lung Transplant 1998; 17: 1017-1023.
15. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant 2009; 28: 231-236.
16. Miller LW, Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant 2006; 25: 756-764.
17. Holdy K, Dembitsky W, Eaton LL, Chillcott S, Stahovich M, Rasmusson B, et al. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant 2005; 24: 1690-1696.
18. Topilsky Y, Oh JK, Shah DK, Boilson BA, Schirger JA, Kushwaha SS, et al. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging 2011; 4: 211-222.
19. Imamura T, Kinugawa K, Shiga T, Endo M, Inaba T, Maki H, et al. A case of late-onset right ventricular failure after implantation of a continuous-flow left ventricular assist device. J Artif Organs 2012 January 17 [Epub ahead of print].
20. Dang NC, Topkara VK, Mercando M, Kay J, Kruger KH, Aboodi MS, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung TransplantJ2006; 25: 1-6.
21. Kavarana MN, Pessin-Minsley MS, Urtecho J, Catanese KA, Flannery M, Oz MC, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: A continuing problem. Ann Thorac Surg 2002; 73: 745-750.
22. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg 2010; 139: 1316-1324.
23. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Second INTERMACS annual report: More than 1,000 primary left ventricular assist device implants. J Heart Lung Transplant 2010; 29: 1-10.
24. Toda K, Fujita T, Kobayashi J, Shimahara Y, Kitamura S, Seguchi O, et al. Impact of preoperative percutaneous cardiopulmonary support on outcome following left ventricular assist device implantation. Circ J 2011; 76: 88-95.